Sunovion360 Epilepsy
View resources to support your efforts to integrate behavioral and physical health for better population health management.
view Resources
Seizure Management Across Care Settings
Listen to experts address seizure management across health care settings from four different care setting perspectives.
Watch Videos
TAAR1: A New Potential Therapeutic Stategy
Take a deeper dice into recent research for Trace Amine Associated Receptor 1 with Dr. Stahl.
View Video
Connect with us
SUNOVION360

LinkedInupdates

Sunovion HEALTH Insights
#Epilepsy Allies is an interactive app-based educational program that is now available on award-winning SunovionHealthInsights.com.

Advance the knowledge of Long-Term Care staff caring for those with intellectual and developmental disabilities (IDD) and elderly at risk of having seizures. Designed for adult learning, featuring micro-lessons, interactive quizzes, and videos.

Learn more: https://lnkd.in/eWUkwQCc

#Epilepsy #LongTermCare
Sunovion HEALTH Insights
The Sunovion Pharmaceuticals Trade Team is looking forward to connecting with our trade partners and colleagues at #NACDS Total Store Expo in Boston on August 26-29.

Connect with us at NACDS by scheduling an onsite strategic business meeting with us: https://lnkd.in/e3yxyfWR

#NACDS #TSE2022 #Trade
Sunovion HEALTH Insights
A Sunovion Field Medical Representative is here for you anytime for the following needs:

• Request a customized educational program for your organization from a range of topics in Psychiatry, Neurology and Respiratory

• Access Sunovion pivotal trial publications

• Learn more about our Independent and Investigator-initiated study grants

• Engage with us at future medical meetings

Connect with us today! Learn More: https://bit.ly/3sNpq87
Sunovion HEALTH Insights
The ability of trace amine-associated receptor 1 (TAAR1) to regulate neurotransmitter circuits important for mood, psychosis, cognition, and reward processing, makes it a potential therapeutic target for serious mental illnesses.(1)

Learn More: https://bit.ly/3PTNnnK

Reference: 1. Pei Y, Asif-Malik A, Canales JJ. Trace amines and the trace amine-associated receptor 1: Pharmacology, neurochemistry, and clinical implications. Front Neurosci. 2016;10:148.
Sunovion HEALTH Insights
Sunovion Pharmaceuticals Market Access is looking forward to high level interactions with PBM partners at #PCMA 2022 Annual Meeting.

Connect with us to schedule a meeting September 18 and 19 in California: https://sunovionhealthinsights.com/connect_with_us
Sunovion HEALTH Insights
Did you know that Bipolar Disorder affects nearly 3% of adults in the US? (1)

Bipolar Disorder is a chronic mood disorder characterized by mood swings from extreme highs (mania) to extreme lows (depression). Bipolar Depression is an important contributor to long-term dysfunction for patients due to psychosocial impairment and impaired quality of life. (2)

As a patient-focused leader in the CNS space, the Medical and Scientific Affairs Team at Sunovion Pharmaceuticals is proud to contribute to relevant and important literature for people living with bipolar depression. #bipolardepression #BPD

To learn more about this publication, connect with your Field Medical Representative: https://bit.ly/3sHZR8J
Sunovion HEALTH Insights
The #Sunovion Neurology team had an exciting week at the 4th Pan American Parkinson’s Disease and Movement Disorders Congress (MDS-PAS) in Miami, Florida! The team supported multiple poster presentations, including one highlighting guidance from a Delphi consensus panel on the use of on-demand therapies for OFF episodes in Parkinson’s Disease. #pascongress #neurology

Connect with our Field Medical team to find out what you missed:
https://bit.ly/3sHZR8J
Sunovion HEALTH Insights
#Sunovion360 supports your efforts to integrate behavioral and physical health for better population health management.

Access the Behavioral Health Screening Toolkit for materials that can be customized for your health plan, system or facility https://bit.ly/3lLbqYG
Sunovion HEALTH Insights
The #SunovionLTC Team is looking forward to #DDNA in San Antonio! We proudly support your mission to educate, empower, and advocate for nurses practicing in the specialty of developmental disability nursing.

Hope to see you at DDNA in San Antonio!
  1. Lewis VA, et al. Health Aff (Millwood). 2014;33(10):1808-1816.